HFMREF
Clinical trials for HFMREF explained in plain language.
Never miss a new study
Get alerted when new HFMREF trials appear
Sign up with your email to follow new studies for HFMREF, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to ease dual Heart-Lung condition
Disease control Recruiting nowThis study tests whether adding macitentan to the standard drug dapagliflozin improves outcomes for people with heart failure and a specific type of high blood pressure in the lungs. 64 adults in South Korea will take either the combo or dapagliflozin alone for 24 weeks. Research…
Matched conditions: HFMREF
Phase: PHASE4 • Sponsor: Gachon University Gil Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New device aims to measure hidden heart stiffness
Knowledge-focused Recruiting nowThis observational study tests a new device (eMyosound LYRA) that uses sound waves to measure stiffness in the heart and liver. Researchers will compare 150 people—some with heart failure, some with a rare heart condition called ATTR-CM, and some healthy volunteers. The goal is t…
Matched conditions: HFMREF
Sponsor: eMyosound SAS • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC